Elucid Bioimaging Inc.’s $80 Million Series C Funding Round

Honigman represented Elucid Bioimaging Inc. in the transaction, and Latham and Watkins represented Elevage Medical Technologies.Elucid Bioimaging Inc. announced it has raised $80 million in Series C financing…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now